Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer. (Q51000641)
Jump to navigation
Jump to search
scientific article published in June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer. |
scientific article published in June 2013 |
Statements
Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer. (English)
1 reference
Laura J Havrilesky
1 reference
Angeles Alvarez Secord
1 reference
Evan R Myers
1 reference
Jason Cory Barnett
1 reference
Jonathan A Ledermann
1 reference
Bercedis L Peterson
1 reference
1 June 2013
1 reference
23
1 reference
5
1 reference
846-852
1 reference
Identifiers
1 reference